Sep 06, 2016 8:30am EDT OPKO to Present Long-acting Human Growth Hormone (hGH-CTP) Phase 2 Pediatric Growth Hormone Deficiency Data at the 55th Annual Meeting of the European Society for Paediatric Endocrinology
Aug 03, 2016 12:14pm EDT OPKO to Announce Second Quarter Operating and Financial Results on August 8, 2016
Jun 21, 2016 2:00am EDT FDA Approves New Drug Application for RAYALDEE® to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease